Aug 31, 2026 · 22 min · 9 segments
Join moderator Lance Burrell and guests Mike Pintek, President, Nuclear & Precision Health Solutions (NPHS) and Dr. Ramji Rajendran, Radiation Oncologist, UroPartners, LLC, Medical Director of…
Ramji RajendranGuest
Mike PintekGuestThe clinical views and opinions expressed in this presentation are those of the speakers and are based on their personal clinical experience.
It should not be considered medical guidance.
Any mention of a specific product is for illustration purposes.
Any verbal evaluations and opinions expressed by clinicians are independent and not approved by Cardinal Health.
The materials and views expressed in this presentation are not necessarily the views of the Specialty Alliance and Ural Partners LLC.
This discussion addresses early stage research.
isotope supply, and operational considerations.
Actinium-225 related applications discussed here are investigational unless and until specifically approved in product labeling.
No statement should be interpreted as a recommendation regarding safety, effectiveness, patient selection, or standard of care use.
Healthcare providers are responsible for all medical decisions regarding the use of any drug products with their patients.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
The clinical views and opinions expressed in this presentation are those of the speakers and are based on their personal clinical experience.
It should not be considered medical guidance.
Any mention of a specific product is for illustration purposes.
Any verbal evaluations and opinions expressed by clinicians are independent and not approved by Cardinal Health.
The materials and views expressed in this presentation are not necessarily the views of the Specialty Alliance and Ural Partners LLC.
This discussion addresses early stage research.
isotope supply, and operational considerations.
Actinium-225 related applications discussed here are investigational unless and until specifically approved in product labeling.
No statement should be interpreted as a recommendation regarding safety, effectiveness, patient selection, or standard of care use.
Healthcare providers are responsible for all medical decisions regarding the use of any drug products with their patients.
